AstraZeneca

$51.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.25 (+0.48%) As of 2:18 PM EDT today

Why Robinhood?

You can buy or sell AstraZeneca and other stocks, options, and ETFs commission-free!

About AZN

AstraZeneca PLC American Depositary Shares, also called AstraZeneca, is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. Read More The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. The listed name for AZN is AstraZeneca PLC American Depositary Shares.

Employees
70,600
Headquarters
Cambridge, Cambridgeshire
Founded
1992
Market Cap
136.14B
Price-Earnings Ratio
63.62
Dividend Yield
2.63
Average Volume
4.03M
High Today
$52.23
Low Today
$51.63
Open Price
$52.03
Volume
2.46M
52 Week High
$64.94
52 Week Low
$36.15

Collections

AZN News

Reuters8h

Study finds AstraZeneca's COVID-19 vaccine follows genetic instructions

FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic LONDON
Reuters9h

UPDATE 2-British midcaps jump on vaccine hopes, fresh stimulus

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Sunak unveils more job support for businesses, w
Reuters16h

AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue

SAO PAULO/FRANKFURT (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by As

AZN Earnings

$0.00
$0.35
$0.70
$1.05
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Nov 5, Pre-Market

You May Also Like

More AZN News

CNBCOct 21

AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. AstraZeneca shares turned negative Wednesday a
CNBCOct 20

AstraZeneca's U.S. coronavirus vaccine trial may resume as soon as this week, sources say

AstraZeneca's Covid-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its
ReutersOct 20

Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources

CHICAGO/WASHINGTON (Reuters) - AstraZeneca Plc's AZN.L COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Fo
BenzingaOct 19

AstraZeneca Gets EU Committee Recommendation For Approval Of Heart Failure, Lung Cancer Treatments

The United Kingdom-based pharmaceutical company, AstraZeneca Plc (NASDAQ: AZN) received The Committee for Medicinal Products for Human Use (CHMP) recommendation
ReutersOct 19

AstraZeneca wins two approval recommendations from EU agency

FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic (Reuter
ReutersOct 16

Factbox: Development of AstraZeneca's potential coronavirus vaccine

(Reuters) - AstraZeneca’s experimental COVID-19 vaccine is one of the most advanced candidates in the race against the novel coronavirus. FILE PHOTO: A test tu